awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41527816-B828C5D1-9B25-4FDD-8689-327ADD7BC03F
Q41527816-B828C5D1-9B25-4FDD-8689-327ADD7BC03F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41527816-B828C5D1-9B25-4FDD-8689-327ADD7BC03F
Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety.
P2860
Q41527816-B828C5D1-9B25-4FDD-8689-327ADD7BC03F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41527816-B828C5D1-9B25-4FDD-8689-327ADD7BC03F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77306150ce3dee2e36d0f4f6c142d27000fb4753
P2860
A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.